Chairman:  Joe Pitts (PA-16)
Public health and quarantine; hospital construction; mental health; biomedical research and development; health information technology, privacy, and cybersecurity; public health insurance (Medicare, Medicaid) and private health insurance; medical malpractice and medical malpractice insurance; the regulation of food, drugs, and cosmetics; drug abuse; the Department of Health and Human Services; the National Institutes of Health; the Centers for Disease Control; Indian Health Service; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.



Joe Pitts (PA), Chairman
Brett Guthrie (KY), Vice Chairman
Ed Whitfield (KY)
John Shimkus (IL)
Tim Murphy (PA)
Michael C. Burgess, M.D. (TX)
Marsha Blackburn (TN)
Cathy McMorris Rodgers (WA)
Leonard Lance (NJ)
Morgan Griffith (VA)
Gus Bilirakis (FL)
Billy Long (MO)
Renee Ellmers (NC)
Larry Bucshon (IN)
Susan Brooks (IN)
Chris Collins (NY)
Joe Barton (TX)
Fred Upton (MI) (Ex Officio)


Gene Green (TX), Ranking Member
Eliot L. Engel (NY)
Lois Capps (CA)
Jan Schakowsky (IL)
G. K. Butterfield (NC)
Kathy Castor (FL)
John Sarbanes (MD)
Doris O. Matsui (CA)
Ben Ray Lujan (NM)
Kurt Schrader (OR)
Joseph P. Kennedy, III (MA)
Tony Cardenas (CA)
Frank Pallone, Jr. (NJ) (Ex Officio)

June 15, 2015 | Press Release

WASHINGTON, DC – The bipartisan leaders of the House Energy and Commerce Committee tomorrow will welcome patients to Capitol Hill to discuss H.R. 6, the 21st Century Cures Act. Chairman Fred Upton (R-MI), Rep. Diana DeGette (D-CO), Health Subcommittee Chairman Joe Pitts (R-PA), Ranking Member Frank Pallone, Jr.

June 15, 2015 | ICYMI

The central goal of H.R. 6, the 21st Century Cures Act, is to help patients live longer, healthier lives. To achieve this goal, Chairman Fred Upton (R-MI) and Rep.

June 12, 2015 | Press Release

WASHINGTON, DC – The House Energy and Commerce Committee today announced its hearing and vote schedule for the week of June 15.

June 12, 2015 | Letter

Excerpt: We remain deeply concerned by the issue of inactivation protocols and procedures for studying dangerous pathogens in our federal research laboratories, an issue that this committee has been overseeing since similar incidents occurred at the CDC more than a year ago. We understand that Dugway was inspected a number of times in the past decade by the CDC’s Division of Select Agent

June 12, 2015 | Press Release

WASHINGTON, DC – Today, Energy and Commerce Committee Chairman Fred Upton (R-MI), Committee Ranking Member Frank Pallone, Jr.